| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf2a3a767ae32dfcda1f4e6642aeadc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9eff92b3c2ed2fc8a9b46ce6889ea4ab |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-8146 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6848 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2016-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a9aab688d0d3bdf47c35afca59abc2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_580ecef434d85c2e3a13b7d13deb468c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4d7b73e13579ecc37b5484cd386551e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23939b3e90ae27b00a20e7f8b397d9f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab4597b0de0582318a62f3c95b29b35f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74a1821f9ab4b225972381c911aecebd |
| publicationDate |
2018-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10151755-B2 |
| titleOfInvention |
Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith |
| abstract |
The invention relates to biomarker assays based on protein/peptide biomarkers which show a pronounced differential behaviour between healthy and cancerous sample proteomes e.g. by mass spectrometric measurement and/or antibody-based assays such as an Enzyme-Linked Immunosorbent Assay (ELISA) determination of the protein biomarkers in serum, plasma or blood itself. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11320435-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11731132-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022155223-A1 |
| priorityDate |
2008-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |